Kirsten Sandstrom with her
husband and three sons.

Kirsten's Legacy

Named in memory of Kirsten Sandstrom, Kirsten's Legacy is TGen's research and clinical program for defeating Adrenocortical Carcinoma (ACC).

TGen, the Translational Genomics Research Institute, is a non-profit Phoenix, Arizona, based institute that employs a number of todays leading genomic researchers studying many types of cancer, including ACC.

ACC is rare: less than 2 individuals in 1 million are affected. When the numbers are that low, few federal or philanthropic dollars flow toward studying the causes or finding a cure. That means fewer advances in diagnoses or therapeutic treatments.

 

Our Mission

The mission of Kirsten’s Legacy is to provide valuable resources to patients and their families while working to cure ACC through identification of new therapies and advancing those discoveries, as quickly as possible, to clinical trials.

How to Get Involved

While ACC is one of most rare and lethal of endocrine cancers, it remains one of the least well funded. Please support our efforts to find new therapies as well as new means of preventing and curing this devastating form of cancer.